Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16407)
All Articles published online
|
Publishing Process of This Article
|
Dec 26, 2017 (publication date) through Feb 21, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Plesa A, Dumontet C, Mattei E, Tagoug I, Hayette S, Sujobert P, Tigaud I, Pages MP, Chelghoum Y, Baracco F, Labussierre H, Ducastelle S, Paubelle E, Nicolini FE, Elhamri M, Campos L, Plesa C, Morisset S, Salles G, Bertrand Y, Michallet M, Thomas X. High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia. World J Stem Cells 2017; 9(12): 227-234 [PMID: PMC5746643 DOI: 10.4252/wjsc.v9.i12.227] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v9/i12/227.htm |
| Number | Citing Articles |
| 1 |
Jesse M. Tettero, Sylvie Freeman, Veit Buecklein, Adriano Venditti, Luca Maurillo, Wolfgang Kern, Roland B. Walter, Brent L. Wood, Christophe Roumier, Jan Philippé, Barbara Denys, Jeffrey L. Jorgensen, Marie C. Bene, Francis Lacombe, Adriana Plesa, Monica L. Guzman, Agnieszka Wierzbowska, Anna Czyz, Lok Lam Ngai, Adrian Schwarzer, Costa Bachas, Jacqueline Cloos, Marion Subklewe, Michaela Fuering-Buske, Francesco Buccisano. Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party. HemaSphere 2022; 6(1): e676 doi: 10.1097/HS9.0000000000000676
|
| 2 |
Yue Sun, Gelan Zhu, Hua Zhong. Minimal residual disease monitoring in acute myeloid leukemia: Focus on MFC‐MRD and treatment guidance for elderly patients. European Journal of Haematology 2024; 112(6): 870 doi: 10.1111/ejh.14187
|
| 3 |
Lok Lam Ngai, Angèle Kelder, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos. MRD Tailored Therapy in AML: What We Have Learned So Far. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.603636
|
| 4 |
Jacqueline Cloos, Lok Lam Ngai, Michael Heuser. Understanding differential technologies for detection of MRD and how to incorporate into clinical practice. Hematology 2023; 2023(1): 682 doi: 10.1182/hematology.2023000454
|
| 5 |
Adriana Plesa, Christophe Roumier, Joris Gutrin, Marie-Virginie Larcher, Marie Balsat, Octavia Cadassou, Fiorenza Barraco, Gaëlle Fossard, Amandine Baudouin, Hélène Labussière, Isabelle Tigaud, Sophie Ducastelle, Sandrine Hayette, Pierre Sujobert, Maël Heiblig, Mohamed Elhamri, Xavier Thomas. Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry. Leukemia Research 2021; 111: 106673 doi: 10.1016/j.leukres.2021.106673
|
| 6 |
Heejoo Han, Ja Min Byun, Dong-Yeop Shin, Sung-Soo Yoon, Youngil Koh, Junshik Hong, Inho Kim, Chansup Lee, Hyeonjoo Yoo, Hongseok Yun, Man Jin Kim, Sung Im Cho, Moon-Woo Seong, Sung Sup Park. Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia. The Korean Journal of Internal Medicine 2021; 36(2): 401 doi: 10.3904/kjim.2020.014
|
| 7 |
Qian Lai, Juan Song, Jie Zha, Huijian Zheng, Manman Deng, Yilong Liu, Wei Lin, Zhi Zhu, Huimin Zhang, Bing Xu, Chaoyong Yang. Microfluidic chip with reversible interface for noninvasive remission status monitoring and prognosis prediction of acute myeloid leukemia. Biosensors and Bioelectronics 2023; 219: 114803 doi: 10.1016/j.bios.2022.114803
|
| 8 |
Lacey Brennan, Aru Narendran. Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia. Stem Cells and Development 2019; 28(19): 1277 doi: 10.1089/scd.2019.0035
|
| 9 |
Vincenzo Maria Perriello, Ilaria Gionfriddo, Roberta Rossi, Francesca Milano, Federica Mezzasoma, Andrea Marra, Orietta Spinelli, Alessandro Rambaldi, Ombretta Annibali, Giuseppe Avvisati, Francesco Di Raimondo, Stefano Ascani, Brunangelo Falini, Maria Paola Martelli, Lorenzo Brunetti. CD123 Is Consistently Expressed on NPM1-Mutated AML Cells. Cancers 2021; 13(3): 496 doi: 10.3390/cancers13030496
|
| 10 |
Sylvia Snauwaert, Farzaneh Rahmani, Bart Vandekerckhove, Tessa Kerre. Cancer Immunology. 2020; : 103 doi: 10.1007/978-3-030-57949-4_4
|
| 11 |
Atefe Rahmati, Sajad Goudarzi, Maryam Sheikhi, Payam Siyadat, Gordon A Ferns, Hossein Ayatollahi. The Emerging Roles of Aldehyde Dehydrogenase in Acute Myeloid Leukemia and Its
Therapeutic Potential. Anti-Cancer Agents in Medicinal Chemistry 2023; 23(3): 246 doi: 10.2174/1871520622666220610154043
|
| 12 |
Shiwen Wu, Wei Zhang, Dongqin Shen, Jianle Lu, Li Zhao. PLCB4 upregulation is associated with unfavorable prognosis in pediatric acute myeloid leukemia. Oncology Letters 2019; doi: 10.3892/ol.2019.10921
|
| 13 |
Weronika Stolpa, Agnieszka Mizia-Malarz, Magdalena Zapała, Bartosz Zwiernik. Can CD34+CD38− lymphoblasts, as likely leukemia stem cells, be a prognostic factor in B-cell precursor acute lymphoblastic leukemia in children?. Frontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1213009
|
| 14 |
Jianbiao Zhou, Jing-Yuan Chooi, Ying Qing Ching, Jessie Yiying Quah, Sabrina Hui-Min Toh, Yvonne Ng, Tuan Zea Tan, Wee-Joo Chng. NF-κB promotes the stem-like properties of leukemia cells by activation of LIN28B. World Journal of Stem Cells 2018; 10(4): 34-42 doi: 10.4252/wjsc.v10.i4.34
|
| 15 |
Diana Hanekamp, Alexander N. Snel, Angèle Kelder, Willemijn J. Scholten, Naeem Khan, Marlen Metzner, Maria Irno‐Consalvo, Mayumi Sugita, Anja de Jong, Sjoerd Oude Alink, Harrie Eidhof, Miriam Wilhelm, Michaela Feuring‐Buske, Jennichjen Slomp, Vincent H. J. van der Velden, Edwin Sonneveld, Monica Guzman, Gail J. Roboz, Francesco Buccisano, Paresh Vyas, Sylvie Freeman, Costa Bachas, Gert J. Ossenkoppele, Gerrit J. Schuurhuis, Jacqueline Cloos. Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting. British Journal of Haematology 2020; 190(6): 891 doi: 10.1111/bjh.16594
|
| 16 |
L.M. Shlapatska, A.S. Polishchuk, D.F. Gluzman. EXPRESSION PROFILE OF SOME MARKERS OF LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA. Oncology 2023; 25(3): 180 doi: 10.15407/oncology.2023.03.180
|
| 17 |
Maël Heiblig, Mohamed Elhamri, Xavier Thomas, Adriana Plesa, Emmanuel Raffoux, Sandrine Hayette. A phase 1 study of chemosensitization with plerixafor plus G-CSF in adults with relapsed acute myeloid leukemia. Leukemia Research 2018; 72: 7 doi: 10.1016/j.leukres.2018.07.017
|
| 18 |
Grégoire Le Meur, Adriana Plesa, Marie-Virginie Larcher, Gaëlle Fossard, Fiorenza Barraco, Sandrine Loron, Marie Balsat, Sophie Ducastelle-Leprêtre, Lila Gilis, Xavier Thomas, Hervé Ghesquières, Isabelle Tigaud, Sandrine Hayette, Sarah Huet, Pierre Sujobert, Myriam Renault, Rubio Marie Thérèse, Mauricette Michallet, Hélène Labussière-Wallet, Maël Heiblig. Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study. Transplantation and Cellular Therapy 2023; 29(1): 38.e1 doi: 10.1016/j.jtct.2022.09.003
|
| 19 |
Teresa Caballero-Velázquez, Olga Pérez-López, Ana Yeguas Bermejo, Eduardo Rodríguez Arbolí, Enrique Colado Varela, Amparo Sempere Talens, María Belén Vidriales, María Solé-Rodríguez, Covadonga Quirós Caso, Estefanía Pérez López, Marta Reinoso Segura, Concepción Prats-Martín, Pau Montesinos, Jose A. Pérez-Simón. Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study. Cancers 2023; 15(5): 1609 doi: 10.3390/cancers15051609
|
| 20 |
Rachid Kharrat, Fatma Ben Lakhal, Hiba Souia, Ines Limam, Hend Ben Naji, Mohamed Abdelkarim. Anticancer effects of Artemisia campestris extract on acute myeloid leukemia cells: an ex vivo study. Medical Oncology 2024; 41(8) doi: 10.1007/s12032-024-02453-y
|
| 21 |
Caroline Dix, Tsun-Ho Lo, Georgina Clark, Edward Abadir. Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going. Journal of Clinical Medicine 2020; 9(6): 1714 doi: 10.3390/jcm9061714
|
| 22 |
Etienne Paubelle, Adriana Plesa, Sandrine Hayette, Mohamed Elhamri, Florence Zylbersztejn, Olivier Hermine, Gilles Salles, Xavier Thomas. Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1. Oncology and Therapy 2019; 7(2): 121 doi: 10.1007/s40487-019-0095-9
|
| 23 |
Maura R.V. Ikoma-Colturato, Alef Rafael Severino, Juliana Fernanda dos Santos Tosi, Camila Marques Bertolucci, Yeda Midori Nakamura Cuoco, Ederson Roberto de Mattos, Iago Colturato, Fernanda Barbieri Rodrigues Silva, Mair Pedro de Souza, Anderson João Simione, Vergilio Antonio Rensi Colturato. Clinical validation of a 10-color flow cytometry panel to detect measurable residual disease in acute myeloid leukemia. Leukemia Research 2024; 140: 107482 doi: 10.1016/j.leukres.2024.107482
|
| 24 |
N.N. Mamaev, A.I. Shakirova, E.V. Morozova, T.L. Gindina. EV/1-Positive Leukemias and Myelodysplastic Syndromes: Theoretical and Clinical Aspects (Literature Review). Clinical oncohematology 2021; 14(1): 103 doi: 10.21320/2500-2139-2021-14-1-103-117
|
| 25 |
Michael Heuser, Sylvie D. Freeman, Gert J. Ossenkoppele, Francesco Buccisano, Christopher S. Hourigan, Lok Lam Ngai, Jesse M. Tettero, Costa Bachas, Constance Baer, Marie-Christine Béné, Veit Bücklein, Anna Czyz, Barbara Denys, Richard Dillon, Michaela Feuring-Buske, Monica L. Guzman, Torsten Haferlach, Lina Han, Julia K. Herzig, Jeffrey L. Jorgensen, Wolfgang Kern, Marina Y. Konopleva, Francis Lacombe, Marta Libura, Agata Majchrzak, Luca Maurillo, Yishai Ofran, Jan Philippe, Adriana Plesa, Claude Preudhomme, Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A. van de Loosdrecht, Bert A. van der Reijden, Adriano Venditti, Agnieszka Wierzbowska, Peter J. M. Valk, Brent L. Wood, Roland B. Walter, Christian Thiede, Konstanze Döhner, Gail J. Roboz, Jacqueline Cloos. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party. Blood 2021; 138(26): 2753 doi: 10.1182/blood.2021013626
|
| 26 |
Jacqueline Cloos, Michael Heuser. Measurable Residual Disease in AML. Clinical Lymphoma Myeloma and Leukemia 2021; 21: S116 doi: 10.1016/S2152-2650(21)01233-7
|
| 27 |
Romain Vazquez, Claire Breal, Loria Zalmai, Chloe Friedrich, Carole Almire, Adrien Contejean, Sylvain Barreau, Eric Grignano, Lise Willems, Benedicte Deau-Fischer, Patricia Franchi, Marguerite Vignon, Justine Decroocq, Rudy Birsen, Lauriane Goldwirt, Sophie Kaltenbach, Lucile Couronne, Michaela Fontenay, Olivier Kosmider, Didier Bouscary, Nicolas Chapuis. Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis. Blood Cancer Journal 2021; 11(3) doi: 10.1038/s41408-021-00448-w
|
| 28 |
Weijie Li. Leukemia. 2022; : 79 doi: 10.36255/exon-publications-leukemia-measurable-residual-disease
|
| 29 |
Mark S. Williams, Naseer J. Basma, Fabio M. R. Amaral, Daniel H. Wiseman, Tim C. P. Somervaille. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08839-9
|